Arora Anil, Sharma Praveen, Tyagi Pankaj, Singla Vikas, Arora Veronica, Bansal Naresh, Toshniwal Jay, Kumar Ashish
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi 110 060, India.
J Clin Exp Hepatol. 2013 Dec;3(4):288-95. doi: 10.1016/j.jceh.2013.08.007. Epub 2013 Sep 20.
The clinical profile of patients with hepatocellular carcinoma (HCC) may differ depending on the etiology of HCC. There is no study from India comparing the clinical profile of patients of HCC due to hepatitis B virus (HBV) infection with other etiologies.
We retrospectively reviewed the records of patients clinically diagnosed as HCC between Nov 2000 and Dec 2012 admitted under a single unit of Department of Gastroenterology at our hospital. We compared the clinical presentation of patients of Hepatitis B virus etiology (HBV group) with other etiologies (Non-HBV group).
One hundred and forty-two patients were included (median age 60 years [range 30-83], 92% males). The etiology was HBV in 56 (39%) and among the non-HBV group (n = 86, 61%) the etiological spectrum was following: alcohol 31 (22%), cryptogenic 26 (18%), HCV 27 (19%), and miscellaneous 2 (1%). The median age of presentation was significantly less for HBV group than in non-HBV (56 [30-77] vs. 62 [42-83] years, P < 0.01). Clinical evidence of cirrhosis was significantly less common in the HBV group than non-HBV group (74% vs 98%, P < 0.01). HBV group had lower CTP score than non-HBV (median CTP score 7 vs 8,P < 0.05). Ascites was more common in non-HBV group than HBV group (65% vs 43%, P = 0.018). The BCLC staging was: A 13%, B 23%, C 35%, and D 29%, and there was no difference in tumor characteristics or BCLC staging between HBV or the non-HBV group.
HBV is a common cause of HCC in India, accounting for 39% of cases. The tumor characteristics of HCC due to HBV is similar to other etiologies, however, HBV causes HCC at an earlier age, and in less advanced or even absence of cirrhosis, thus further consolidating the directly carcinogenic potential of HBV.
肝细胞癌(HCC)患者的临床特征可能因HCC的病因不同而有所差异。印度尚无研究比较乙型肝炎病毒(HBV)感染所致HCC患者与其他病因所致HCC患者的临床特征。
我们回顾性分析了2000年11月至2012年12月间我院胃肠病科单一病房收治的临床诊断为HCC患者的病历。我们比较了乙型肝炎病毒病因组(HBV组)与其他病因组(非HBV组)患者的临床表现。
共纳入142例患者(中位年龄60岁[范围30 - 83岁],92%为男性)。病因是HBV的有56例(39%),在非HBV组(n = 86,61%)中,病因谱如下:酒精性31例(22%),隐源性26例(18%),丙型肝炎病毒(HCV)27例(19%),其他2例(1%)。HBV组的中位发病年龄显著低于非HBV组(56[30 - 77]岁对62[42 - 83]岁,P < 0.01)。HBV组肝硬化的临床证据显著少于非HBV组(74%对98%,P < 0.01)。HBV组的CTP评分低于非HBV组(中位CTP评分7对8,P < 0.05)。腹水在非HBV组比HBV组更常见(65%对43%,P = 0.018)。巴塞罗那临床肝癌(BCLC)分期为:A期13%,B期23%,C期35%,D期29%,HBV组与非HBV组之间的肿瘤特征或BCLC分期无差异。
HBV是印度HCC的常见病因,占病例的39%。HBV所致HCC与其他病因所致HCC的肿瘤特征相似,然而,HBV导致HCC的发病年龄更早,且肝硬化程度较轻甚至无肝硬化,从而进一步证实了HBV的直接致癌潜力。